UNITED THERAPEUTICS Corp

SEC 4 · Filed

0001673232-26-000013Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 15, 2026

Exercise or conversion by BENKOWITZ MICHAEL

Security
Restricted Stock Units
Code
M
Shares
15,592
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-03-15",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.",
    "F2": "Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.",
    "F5": "Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023."
  },
  "owners": [
    {
      "cik": "0001673232",
      "name": "BENKOWITZ MICHAEL",
      "roles": [
        "officer"
      ],
      "title": "PRESIDENT AND COO"
    }
  ],
  "ownership": "I",
  "post_shares": "0.00",
  "price": "0.00",
  "row": 2,
  "rule_10b5_1": "false",
  "security": "Restricted Stock Units",
  "shares": "15592.00",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "15592.00"
}
Insider transactionsEvent date Mar 15, 2026

Exercise or conversion by BENKOWITZ MICHAEL

Security
Restricted Stock Units
Code
M
Shares
17,790
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-03-15",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.",
    "F2": "Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.",
    "F5": "Shares received upon vesting of performance-based restricted stock units on March 15, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. These restricted stock units were granted on March 15, 2023."
  },
  "owners": [
    {
      "cik": "0001673232",
      "name": "BENKOWITZ MICHAEL",
      "roles": [
        "officer"
      ],
      "title": "PRESIDENT AND COO"
    }
  ],
  "ownership": "I",
  "post_shares": "0.00",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Restricted Stock Units",
  "shares": "17790.00",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "17790.00"
}
Insider transactionsEvent date Mar 15, 2026

Payment of exercise price or tax by delivery of securities by BENKOWITZ MICHAEL

Security
Common Stock
Code
F
Shares
6,869
Price per share
536.12
Structured facts
{
  "code": "F",
  "date": "2026-03-15",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.",
    "F3": "Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units."
  },
  "owners": [
    {
      "cik": "0001673232",
      "name": "BENKOWITZ MICHAEL",
      "roles": [
        "officer"
      ],
      "title": "PRESIDENT AND COO"
    }
  ],
  "ownership": "I",
  "post_shares": "19046.00",
  "price": "536.12",
  "row": 4,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "6869.00",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 15, 2026

Payment of exercise price or tax by delivery of securities by BENKOWITZ MICHAEL

Security
Common Stock
Code
F
Shares
7,837
Price per share
536.12
Structured facts
{
  "code": "F",
  "date": "2026-03-15",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.",
    "F3": "Represents the number of shares withheld by United Therapeutics for tax purposes, upon vesting of restricted stock units."
  },
  "owners": [
    {
      "cik": "0001673232",
      "name": "BENKOWITZ MICHAEL",
      "roles": [
        "officer"
      ],
      "title": "PRESIDENT AND COO"
    }
  ],
  "ownership": "I",
  "post_shares": "25915.00",
  "price": "536.12",
  "row": 3,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "7837.00",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 15, 2026

Exercise or conversion by BENKOWITZ MICHAEL

Security
Common Stock
Code
M
Shares
15,592
Price per share
Unreported
Structured facts
{
  "code": "M",
  "date": "2026-03-15",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.",
    "F2": "Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power."
  },
  "owners": [
    {
      "cik": "0001673232",
      "name": "BENKOWITZ MICHAEL",
      "roles": [
        "officer"
      ],
      "title": "PRESIDENT AND COO"
    }
  ],
  "ownership": "I",
  "post_shares": "33752.00",
  "price": null,
  "row": 2,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "15592.00",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 15, 2026

Exercise or conversion by BENKOWITZ MICHAEL

Security
Common Stock
Code
M
Shares
17,790
Price per share
Unreported
Structured facts
{
  "code": "M",
  "date": "2026-03-15",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.",
    "F2": "Securities held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power."
  },
  "owners": [
    {
      "cik": "0001673232",
      "name": "BENKOWITZ MICHAEL",
      "roles": [
        "officer"
      ],
      "title": "PRESIDENT AND COO"
    }
  ],
  "ownership": "I",
  "post_shares": "17790.00",
  "price": null,
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "17790.00",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}